A detailed history of Norden Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Norden Group LLC holds 237,006 shares of AMGN stock, worth $72.5 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
237,006
Previous 7,228 3179.0%
Holding current value
$72.5 Million
Previous $2.08 Billion 3136.8%
% of portfolio
0.75%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$268.87 - $324.56 $60.4 Million - $72.9 Million
-224,561 Reduced 94.75%
12,445 $3.54 Billion
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $61.8 Million - $74.6 Million
229,778 Added 3179.0%
237,006 $67.4 Billion
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $580,694 - $655,092
2,271 Added 45.81%
7,228 $2.08 Billion
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $1.08 Million - $1.35 Million
4,957 New
4,957 $1.33 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $164B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.